What is Sensi.AI?
Sensi.AI operates at the intersection of artificial intelligence and geriatric care, providing the world's first in-home 24/7 virtual care agent. By utilizing sophisticated audio AI technology, the platform offers long-term care providers unprecedented insights into patient well-being and operational efficiency. This innovation addresses critical labor shortages and quality-of-care challenges within the healthcare sector, effectively transforming how facilities manage resident safety and staff performance. As a category-defining entity, Sensi.AI is uniquely positioned to capture significant market share in the rapidly expanding digital health landscape, where the demand for automated, non-intrusive monitoring solutions is reaching an inflection point.
How much funding has Sensi.AI raised?
Sensi.AI has raised a total of $93.5M across 4 funding rounds:
Angel/Seed
$3.5M
Series A
$14M
Series B
$31M
Series C
$45M
Angel/Seed (2021): $3.5M with participation from Flint Capital
Series A (2022): $14M led by Flint Capital, Entree Capital, and Homeward Ventures
Series B (2024): $31M supported by Flint Capital, Zeev Ventures, Secret Chord Ventures, Jibe Ventures, and Insight Partners
Series C (2025): $45M featuring Insight Partners and Qumra Capital
Key Investors in Sensi.AI
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies, providing capital and operational support to help businesses scale from early stage to IPO.
Qumra Capital
Qumra Capital is a venture capital fund based in Israel that focuses on late-stage technology companies with proven market fit, seeking to transform businesses into global market leaders.
Flint Capital
Flint Capital Fund specializes in venture capital investments, focusing on providing financial support to innovative startups and growth-stage companies across various sectors.
What's next for Sensi.AI?
With the successful closure of this major strategic investment, Sensi.AI is poised to transition into a phase of aggressive market penetration and technological refinement. The company's strategic roadmap likely includes scaling its enterprise software capabilities to support larger healthcare networks and enhancing its AI models to provide deeper clinical insights. By maintaining a focus on operational excellence and leveraging the expertise of its seasoned investor base, Sensi.AI is well-equipped to navigate the complexities of the healthcare regulatory environment while continuing to set new standards for in-home care technology. Future growth will likely center on deepening integration with existing electronic health record systems and expanding its reach into new international markets.
See full Sensi.AI company page
